Health-related quality of life (HRQoL) in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with olaparib in combination with abiraterone.

Affiliation auteurs!!!! Error affiliation !!!!
TitreHealth-related quality of life (HRQoL) in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with olaparib in combination with abiraterone.
Type de publicationJournal Article
Year of Publication2019
AuteursClarke NW, Thiery-Vuillemin A, Wiechno PJ, Alekseev B, Sala N, Jones R, Kocak I, Chiuri VEmanuele, Jassem J, Flechon A, Redfern C, Goessl CDietrich, Burgents J, Gresty C, Degboe A, Saad F
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume37
Date PublishedMAR 1
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/JCO.2019.37.7_suppl.234